171 related articles for article (PubMed ID: 16718772)
1. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.
Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS
World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772
[TBL] [Abstract][Full Text] [Related]
2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
3. [Screen and identification of serum protein biomarkers in gastric cancer].
Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656
[TBL] [Abstract][Full Text] [Related]
4. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
5. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
[TBL] [Abstract][Full Text] [Related]
6. Identification of gastric cancer patients by serum protein profiling.
Ebert MP; Meuer J; Wiemer JC; Schulz HU; Reymond MA; Traugott U; Malfertheiner P; Röcken C
J Proteome Res; 2004; 3(6):1261-6. PubMed ID: 15595736
[TBL] [Abstract][Full Text] [Related]
7. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
8. Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning.
Zhang X; Wang B; Zhang XS; Li ZM; Guan ZZ; Jiang WQ
BMC Cancer; 2007 Dec; 7():235. PubMed ID: 18163913
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Lim JY; Cho JY; Paik YH; Chang YS; Kim HG
Int J Biol Markers; 2007; 22(4):281-6. PubMed ID: 18161659
[TBL] [Abstract][Full Text] [Related]
10. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
12. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Mohri Y; Mohri T; Wei W; Qi YJ; Martin A; Miki C; Kusunoki M; Ward DG; Johnson PJ
Br J Cancer; 2009 Jul; 101(2):295-302. PubMed ID: 19550422
[TBL] [Abstract][Full Text] [Related]
13. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
[TBL] [Abstract][Full Text] [Related]
14. The proteomics approach to find biomarkers in gastric cancer.
Ryu JW; Kim HJ; Lee YS; Myong NH; Hwang CH; Lee GS; Yom HC
J Korean Med Sci; 2003 Aug; 18(4):505-9. PubMed ID: 12923326
[TBL] [Abstract][Full Text] [Related]
15. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
[TBL] [Abstract][Full Text] [Related]
16. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
17. High-resolution serum proteomic features for ovarian cancer detection.
Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
[TBL] [Abstract][Full Text] [Related]
18. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
20. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
